ScholarIQanswers from OpenAlex & ORCID
Miguel A. Cuesta
ResearcherPublications, citations & collaboration network
Miguel A. Cuesta is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Miguel A. Cuesta have?
ScholarIQindexed works
Miguel A. Cuesta has 439 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Miguel A. Cuesta have?
ScholarIQcitation count
Miguel A. Cuesta has 31,622 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Miguel A. Cuesta?
ScholarIQh-index
Miguel A. Cuesta has an h-index of 76 in OpenAlex.
What is the i10-index of Miguel A. Cuesta?
ScholarIQi10-index
Miguel A. Cuesta has an i10-index of 221 in OpenAlex.
What is the ORCID of Miguel A. Cuesta?
ScholarIQorcid
The ORCID for Miguel A. Cuesta is on the source record.
What is the OpenAlex record for Miguel A. Cuesta?
ScholarIQopenalex
The OpenAlex for Miguel A. Cuesta is on the source record.
What are the most-cited papers on Miguel A. Cuesta?
ScholarIQmost cited works
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
Pieter van Hagen, Maarten C.C.M. Hulshof, J. Jan B. van Lanschot, Ewout W. Steyerberg, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Dick J. Richel, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, F.J.W. ten Kate, G.J. Creemers, C.J.A. Punt, John Theodorus Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, H.W. Tilanus, Ate van der Gaast
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
Joël Shapiro, J. Jan B. van Lanschot, Maarten C.C.M. Hulshof, Pieter van Hagen, Mark I. van Berge Henegouwen, Bas P. L. Wijnhoven, Hanneke W.M. van Laarhoven, Grard A. P. Nieuwenhuijzen, Geke A.P. Hospers, Johannes J. Bonenkamp, Miguel A. Cuesta, R.J.B. Blaisse, Olivier R. Busch, Fiebo J.W. ten Kate, Geert-Jan Creemers, Cornelis J.A. Punt, John Th. M. Plukker, Henk M.W. Verheul, Ernst Jan Spillenaar Bilgen, Herman van Dekken, Maurice J.C. van der Sangen, Tom Rozema, Katharina Biermann, Jannet C. Beukema, Anna H.M. Piet, Caroline M. van Rij, Janny G. Reinders, Hugo W. Tilanus, Ewout W. Steyerberg, Ate van der Gaast
Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial
Surya S. A. Y. Biere, Mark I. van Berge Henegouwen, K. W. Maas, Luigi Bonavina, Camiel Rosman, Josep Roig García, Suzanne S. Gisbertz, Jean H. G. Klinkenbijl, Markus W. Hollmann, Elly SM de Lange, H. Jaap Bonjer, Donald L. van der Peet, Miguel A. Cuesta
Laparoscopic versus open surgery for rectal cancer (COLOR II): short-term outcomes of a randomised, phase 3 trial
Martijn HGM van der Pas, Eva Haglind, Miguel A. Cuesta, Alois Fürst, Antonio M. Lacy, Wim C.J. Hop, H. Jaap Bonjer
A Randomized Trial of Laparoscopic versus Open Surgery for Rectal Cancer
H. Jaap Bonjer, Charlotte L. Deijen, Gabor A. Abis, Miguel A. Cuesta, M. H. G. M. van der Pas, Elly S.M. de Lange–de Klerk, Antonio M. Lacy, Willem A. Bemelman, John Andersson, Eva Angenete, Jacob Rosenberg, Alois Fuerst, Eva Haglind